California Nanotechnologies Corp.
CNO.V · TSXV
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.28 | -0.29 | 0.04 | -0.72 |
| FCF Yield | -2.67% | 0.20% | 1.53% | 0.76% |
| EV / EBITDA | -110.45 | -82.78 | 421.86 | 122.04 |
| Quality | ||||
| ROIC | -8.82% | -11.38% | -22.30% | 16.25% |
| Gross Margin | -2.04% | 56.95% | 69.36% | 77.08% |
| Cash Conversion Ratio | 1.00 | -0.16 | -1.21 | 17.07 |
| Growth | ||||
| Revenue 3-Year CAGR | 18.73% | 35.34% | 50.60% | 49.01% |
| Free Cash Flow Growth | -899.57% | -87.41% | 5.24% | -44.23% |
| Safety | ||||
| Net Debt / EBITDA | -9.88 | -4.39 | 21.65 | 4.84 |
| Interest Coverage | -10.63 | -15.53 | -94.59 | 9.99 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 67.64 | -45.25 | -110.23 | -95.52 |